Table 2.
Summary results of scaling assumption tests.
| N a | Item-internal consistency | Item-discriminant validity | |||
|---|---|---|---|---|---|
| Range of correlationsb | # Success/totalc | Range of correlationsd | # Success/totale | ||
| QLQ-C30 | |||||
| Global health status/QoL | 2 | 0.85 | 2/2 | 0.34–0.59 | 16/16 |
| Functional scales | |||||
| Physical functioning | 5 | 0.35–0.73 | 4/5 | 0.17–0.55 | 27/40 |
| Role functioning | 2 | 0.82 | 2/2 | 0.27–0.64 | 15/16 |
| Emotional functioning | 4 | 0.62–0.74 | 4/4 | 0.21–0.68 | 29/32 |
| Cognitive functioning | 2 | 0.40 | 2/2 | 0.10–0.47 | 2/16 |
| Social functioning | 2 | 0.65 | 2/2 | 0.22–0.51 | 10/16 |
| Symptom scales/items | |||||
| Fatigue | 3 | 0.75–0.83 | 3/3 | 0.27–0.57 | 22/24 |
| Nausea and vomiting | 2 | 0.66 | 2/2 | 0.08–0.41 | 16/16 |
| Pain | 2 | 0.67 | 2/2 | 0.14–0.56 | 12/16 |
|
| |||||
| QLQ-MY20 | |||||
| Disease symptoms | 6 | 0.18–0.68 | 5/6 | 0.01–0.51 | 9/12 |
| Side effects of treatment | 9f | 0.23–0.57 | 5/9 | 0.03–0.43 | 6/18 |
| Future perspective | 3 | 0.60–0.69 | 3/3 | 0.16–0.38 | 6/6 |
aNumber of items and number of item-internal consistency tests per scale (single-item scales excluded).
bRange of correlations between items and hypothesized scale corrected for overlap.
cNumber of correlations exceeding the 0.40 standard/total number of correlations.
dRange of correlations between items and other scales.
eNumber of successful discriminant validity tests/total number of discriminant validity tests.
fItem no.42 concerned only 10% of the sample suffering hair loss and was omitted from this analysis.